Skip to main content

Proceeding contribution from Kevin Barron (Labour) in the House of Commons on Thursday, 8 December 2005. It occurred during Estimates day on Department of Health.


Department of Health

Repeat prescriptions are sometimes numerically limited so that one has one, four or five out of six. After that, it is doctors’ clinical responsibility to ensure that they see the patient before any further prescribing of the drug. However, what happens in the real world is not always consistent with that. Occasionally, that is at great cost to the individual concerned, but it is always at great cost to everyone because safety incidents cost the NHS approximately £2 billion a year in bed days in our acute sector. They are problems for clinicians and everyone.


Secondary information

Type
Proceeding contribution
Reference
440 c1022 
Session
2005-06
Chamber / Committee
House of Commons chamber
Subjects
Advertising Licensing Expenditure Drugs Government departments Industry Prescription drugs Department of Health Medicines and Healthcare products Regulatory Agency Research Regulation Safety National Institute for Health and Care Excellence Registration Clinical trials
Link
View this Proceeding contribution on www.publications.parliament.uk